Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men.
Genital human papillomavirus (HPV) infection is one of the most commonly diagnosed sexually transmitted infections world-wide. Over the last two decades, research has established a strong causal link between specific types of HPV infection and cancer, particularly cervical, anal, vulvar/vaginal, penile, and oropharyngeal cancer. Limited epidemiological studies of anogenital HPV infection have been conducted in Hispanic populations (including Puerto Rico), and population-based incidence and prevalence estimates of HPV infection among Hispanics are limited. Studies that evaluate knowledge and awareness of HPV among men are also scarce. With the world-wide introduction of two new prophylactic vaccines against high-risk HPVs causing cervical cancer, and the recent FDA approval of the quadrivalent vaccine in preventing genital warts in men, there is an urgency to determine the burden of HPV in Hispanic populations before vaccine programs are implemented on a widespread basis. Knowledge and acceptability of the vaccine prior to implementation of these programs are also necessary to allow a targeted assessment. This review article summarizes existing research on HPV infection and HPV-related morbidities in men, with a particular emphasis on Hispanic men in the United States and Puerto Rico. Three major areas are discussed: (1) genital warts, (2) HPV and related cancers and (3) biobehavioral and psychosocial factors related to HPV infection and vaccination. Specific recommendations for advancing HPV research and knowledge among Hispanic populations also are suggested.
Colón-López
Vivian
V
Center for Evaluation and Sociomedical Research, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico. vivian.colon@upr.edu
Ortiz
Ana P
AP
Palefsky
Joel
J
D035843:Biomedical Research; D017281:Cost of Illness; D006293:Health Promotion; D006630:Hispanic or Latino; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications / Q000517:prevention & control* / Q000523:psychology / Q000821:virology*; D030361:Papillomavirus Infections / Q000150:complications* / Q000517:prevention & control* / Q000523:psychology
J Adolesc Health. 2010 Apr;46(4 Suppl):S12-9
20307839
BMC Cancer. 2009 Apr 28;9:129
19400958
Semin Cancer Biol. 2004 Dec;14(6):453-71
15489139
J Community Health. 2000 Feb;25(1):67-78
10706210
Herpes. 2004 Apr;11(1):8-11
15115631
Am J Public Health. 2002 Mar;92(3):378-81
11867314
Public Health Genomics. 2009;12(5-6):291-307
19684442
Int J Cancer. 2006 Oct 15;119(8):1934-9
16708372
J Infect Dis. 2010 May 1;201(9):1340-3
20350160
Br J Cancer. 2001 Jul 6;85(1):46-54
11437401
CA Cancer J Clin. 2003 Jan-Feb;53(1):5-26
12568441
Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S2-5
17938014
J Natl Cancer Inst. 2005 Jun 15;97(12):896-905
15956651
Cancer. 2008 Nov 15;113(10 Suppl):2892-900
18980293
Perspect Sex Reprod Health. 2004 Jan-Feb;36(1):6-10
14982671
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Mar;99(3):311-5
15716837
Genitourin Med. 1997 Jun;73(3):174-80
9306896
Sex Transm Dis. 2007 Jul;34(7):479-84
17413536
J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30
19648510
Arch Otolaryngol Head Neck Surg. 2009 Feb;135(2):180-8
19221247
Vaccine. 2008 Aug 19;26 Suppl 10:K17-28
18847554
J Pediatr Adolesc Gynecol. 2009 Aug;22(4):205-15
19646665
JAMA. 2004 Jul 14;292(2):171-9
15249566
N Engl J Med. 2002 Apr 11;346(15):1105-12
11948269
Sex Transm Dis. 2001 May;28(5):277-80
11354266
J Infect Dis. 2005 Feb 1;191 Suppl 1:S42-54
15627230
Dis Markers. 2007;23(4):261-72
17627061
Gynecol Oncol. 2010 May;117(2 Suppl):S15-9
20138345
Int J STD AIDS. 2001 Apr;12(4):211-5
11319969
Infect Agent Cancer. 2010 May 14;5:10
20470399
Prev Med. 2007 Aug-Sep;45(2-3):107-14
17628649
J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83
14652239
Int J Addict. 1990 Jun;25(6):665-91
2265869
AIDS. 2008 Jun 19;22(10):1203-11
18525266
J Infect Dis. 1997 Aug;176(2):353-61
9237700
Sex Transm Dis. 2009 Jan;36(1):58-62
18830138
Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1710-6
16030106
J Infect Dis. 2006 Oct 15;194(8):1044-57
16991079
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1077-83
19318438
Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25
16949997
Am J Obstet Gynecol. 2008 May;198(5):500.e1-7
18455524
Int J Epidemiol. 2010 Feb;39(1):166-81
20022926
Sex Transm Dis. 2008 Apr;35(4):357-60
18360316
Cancer. 2008 Nov 15;113(10 Suppl):2883-91
18980292
Lancet Oncol. 2010 Aug;11(8):781-9
20451455
Ethn Health. 2009 Dec;14(6):607-24
19953392
Cir Cir. 2007 May-Jun;75(3):151-5
17659164
Vaccine. 2008 Aug 19;26 Suppl 10:K53-61
18847557
P R Health Sci J. 2011 Jun;30(2):65-8
21682148
Head Neck. 2004 Sep;26(9):778-84
15350023
Oral Oncol. 2000 Jan;36(1):106-15
10889929
Cancer Causes Control. 1999 Feb;10(1):27-33
10334639
J Dent Res. 2009 Apr;88(4):300-6
19407148
Br J Cancer. 2002 Mar 4;86(5):705-11
11875730
Curr Opin HIV AIDS. 2009 Jan;4(1):52-6
19339939
Sex Transm Infect. 2010 Jun;86(3):241-6
19951936
Contraception. 2009 Aug;80(2):158-62
19631791
Int J Cancer. 2009 Mar 15;124(6):1251-7
19089913
Cancer. 2008 Nov 15;113(10 Suppl):2901-9
18980273
Arch Med Res. 2008 Feb;39(2):189-97
18164962
Epidemiol Rev. 2004;26:22-35
15234945
J Infect Dis. 2009 May 1;199(9):1263-9
19320589
Sex Transm Dis. 2004 Oct;31(10):601-7
15388997
Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S24-6
17938015
Cancer. 2007 Oct 1;110(7):1429-35
17724670
Sex Transm Infect. 2002 Jun;78(3):215-8
12238658
Clin Infect Dis. 2002 Nov 1;35(9):1127-34
12384848
J Am Board Fam Med. 2009 Jan-Feb;22(1):34-42
19124631
Sex Transm Dis. 2010 Jun;37(6):386-91
20081557
Int J STD AIDS. 2005 Oct;16(10):667-70
16212712
J Infect Dis. 2009 Apr 1;199(7):965-73
19239366
J Infect Dis. 2009 Feb 1;199(3):362-71
19133808
J Infect Dis. 2003 Apr 1;187(7):1064-70
12660920
Int J Cancer. 2006 Jun 15;118(12):3030-44
16404738
Braz J Otorhinolaryngol. 2006 Mar-Apr;72(2):272-82
16951865
P R Health Sci J. 2010 Sep;29(3):241-9
20799511